Evidence for brain glial activation in chronic pain patients
Open accessThe DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Abstract
Although substantial evidence has established that microglia and astrocytes play a key role in the establishment and maintenance of persistent pain in animal models, the role of glial cells in human pain disorders remains unknown. Here, using the novel technology of integrated positron emission tomography-magnetic resonance imaging and the recently developed radioligand (11)C-PBR28, we show increased brain levels of the translocator protein (TSPO), a marker of glial activation, in patients with chronic low back pain. As the Ala147Thr polymorphism in the TSPO gene affects binding affinity for (11)C-PBR28, nine patient-control pairs were identified from a larger sample of subjects screened and genotyped, and compared in a matched-pairs design, in which each patient was matched to a TSPO polymorphism-, age- and sex-matched control subject (seven Ala/Ala and two Ala/Thr, five males and four females in each group; median age difference: 1 year; age range: 29-63 for patients and 28-65 for controls). Standardized uptake values normalized to whole brain were significantly higher in patients than controls in multiple brain regions, including thalamus and the putative somatosensory representations of the lumbar spine and leg. The thalamic levels of TSPO were negatively correlated with clinical pain and circulating levels of the proinflammatory citokine interleukin-6, suggesting that TSPO expression exerts pain-protective/anti-inflammatory effects in humans, as predicted by animal studies. Given the putative role of activated glia in the establishment and or maintenance of persistent pain, the present findings offer clinical implications that may serve to guide future studies of the pathophysiology and management of a variety of persistent pain conditions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although Blacks are less likely than non-Hispanic Whites to report experiencing depression and anxiety, the chronicity of Major Depressive Disorder is higher among Black individuals than Caucasians, and Black patients are less likely to receive effective treatment and more likely than Whites to rate their depression as severe and disabling 237–241.”
From Evaluating psychosocial contributions to chronic pain outcomes (2018) · cites this paper as [239]
In the citing paper
“Black patients are less likely to receive effective treatment and more likely than Whites to rate their depression as severe and disabling 237–241.”
From Evaluating psychosocial contributions to chronic pain outcomes (2018) · cites this paper as [239]
In the citing paper
“PET imaging studies in humans54, as well as electrophysiological and immunohistochemical studies in rodent pain models, suggest a prominent role for glial cells100 or other immune cells80”
From The dorsolateral prefrontal cortex in acute and chronic pain (2017) · cites this paper as [54]
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
Advances in functional and structural MR image analysis and implementation as FSL
Smith, S. M., Jenkinson, M., Woolrich, M. W., Beckmann, C. F., Behrens, T. E. J., Johansen-Berg, H., Bannister, P. R., De Luca, M., Drobnjak, I., Flitney, D. E., et al. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.07.051 · Cited by 13,630 · cited 1×
“uk/fsl/) (Smith et al., 2004).”
Cortical Surface-Based Analysis
Dale, A. M., Fischl, B., & Sereno, M. I. (1999) · NeuroImage · doi:10.1006/nimg.1998.0395 · Cited by 10,910 · cited 1×
“edu) (Dale et al., 1999) that performs a rigid-body registration of a functional volume to its relative FreeSurfer anatomical volume with Normalised Mutual Information using spm_coreg from the SPM suite (http://www.”
MethodNonparametric permutation tests for functional neuroimaging: A primer with examples
Nichols, T. E., & Holmes, A. P. (2002) · Human Brain Mapping · doi:10.1002/hbm.1058 · Cited by 6,256
SMITH, S., & NICHOLS, T. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.03.061 · Cited by 5,250
The short-form McGill pain questionnaire
Melzack, R. (1987) · Pain · doi:10.1016/0304-3959(87)91074-8 · Cited by 4,368
BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain
Coull, J. A. M., Beggs, S., Boudreau, D., Boivin, D., Tsuda, M., Inoue, K., Gravel, C., Salter, M. W., & De Koninck, Y. (2005) · Nature · doi:10.1038/nature04223 · Cited by 1,965
Frackowiak, R. S. J. (1997) · Cited by 1,795
P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury
Tsuda, M., Shigemoto-Mogami, Y., Koizumi, S., Mizokoshi, A., Kohsaka, S., Salter, M. W., & Inoue, K. (2003) · Nature · doi:10.1038/nature01786 · Cited by 1,563
Research works printed but not linked: 1
- Friston, 2003, Introduction: experimental design and statistical parametric mapping
Cited by
Items 201–300 of 503
Staal, R. G. W., Khayrullina, T., Zhang, H., Davis, S., Fallon, S. M., Cajina, M., Nattini, M. E., Hu, A., Hua, Z., Poda, S. B., et al. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.11.031 · Cited by 34
White matter microstructure degenerates in patients with postherpetic neuralgia
Chen, F., Chen, F., Shang, Z., Shui, Y., Wu, G., Liu, C., Lin, Z., Lin, Y., Yu, L., Kang, D., et al. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.07.023 · Cited by 34
“On the other hand, increasing evidence have clearly demonstrated that inflammatory response and glial activation in the central nervous system played a crucial role in the introduction and maintenance of peripheral neuropathic pain[1, 4, 18, 22, 29].”
Assessment of simplified ratio-based approaches for quantification of PET [11C]PBR28 data
Matheson, G. J., Plavén‐Sigray, P., Forsberg, A., Varrone, A., Farde, L., & Červenka, S. (2017) · EJNMMI Research · doi:10.1186/s13550-017-0304-1 · Cited by 34
Greenmyer, J. R., Gaultney, R. A., Brissette, C. A., & Watt, J. A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00811 · Cited by 39
“In light of recent work on the connection of glia to persistent pain (Loggia et al., 2015; Ji et al., 2016), the contribution of neurotrophins, growth factors, and neurotransmitters to cellular responses to B. burgdorferi may offer clues to chronic pain often reported by patients with posttreatment…”
BackgroundFujita, M., Tamano, R., Yoneda, S., Omachi, S., Yogo, E., Rokushima, M., Shinohara, S., Sakaguchi, G., Hasegawa, M., & Asaki, T. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.06.009 · Cited by 32
Weerasekera, A., Morrissey, E. J., Kim, M., Saha, A., Lin, Y., Alshelh, Z., Torrado-Carvajal, Á., Albrecht, D., Akeju, O., Kwon, Y., et al. (2021) · Pain · doi:10.1097/j.pain.0000000000002198 · Cited by 37
“15mm voxel was placed in the left thalamus because this was the region showing the largest effect size in our previous PET study of neuroinflammation in chronic lower back patients (cLBP).(49) Of”
MethodSelf-citationMicroglial role in the development of chronic pain
Suter, M. R. (2016) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000373 · Cited by 32
PET Imaging of Human Brown Adipose Tissue with the TSPO Tracer [11C]PBR28
Ran, C., Albrecht, D., Bredella, M. A., Yang, J., Yang, J., Liang, S. H., Cypess, A. M., Loggia, M. L., Atassi, N., & Moore, A. V. (2017) · Molecular Imaging and Biology · doi:10.1007/s11307-017-1129-z · Cited by 34
Self-citationCurrent perspectives on mitochondrial dysfunction in migraine
Bohra, S. K., Achar, R. R., Chidambaram, S. B., Pellegrino, C., Laurin, J., Masoodi, M., & Srinivasan, A. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15676 · Cited by 32
“X-linked inheritance has been a subject of discussion for many decades considering the facts that migraine is approximately three times more prevalent among women than men (MacGregor, 2004), suggesting that maternal transmission is more prevalent (Lemos et al., 2012).”
BackgroundMicroglia: sculptors of neuropathic pain?
Ward, H. L., & West, S. J. (2020) · Royal Society Open Science · doi:10.1098/rsos.200260 · Cited by 38
“Indeed, imaging of activated microglia with a positron emission tomography (PET) radioligand to a translocator protein (TSPO) in patients with chronic low back pain shows upregulation in higher regions, and that the levels of activated microglia correlated with pain and IL-6 levels [16].”
BackgroundTian, G., Luo, X., Tang, C., Cheng, X., Chung, S. K., Xia, Z., Cheung, C. W., & Guo, Q. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.11.030 · Cited by 31
“Increasing bodyof studies indicates that glial cells are involved in the abnormal pain perception in animals under different pathological conditions [6], and in the patients suffering from chronic pain [22].”
BackgroundEvidence that dry eye is a comorbid pain condition in a U.S. veteran population
Lee, C. J., Levitt, R. C., Felix, E. R., Sarantopoulos, C. D., & Galor, A. (2017) · PAIN Reports · doi:10.1097/pr9.0000000000000629 · Cited by 32
Beating pain with psychedelics: Matter over mind?
Elman, I., Pustilnik, A. C., & Borsook, D. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.12.005 · Cited by 30
Vallejo, R., Gupta, A., Kelley, C. A., Vallejo, A., Rink, J. A., Williams, J. M., Cass, C. L., Smith, W. J., Benyamin, R. M., & Cedeño, D. L. (2019) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.12964 · Cited by 29
Horowitz, R. I., & Freeman, P. R. (2018) · Healthcare · doi:10.3390/healthcare6040129 · Cited by 34
Brezić, N., Gligorevic, S., Sič, A., & Knežević, N. N. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47040259 · Cited by 32
“Neuroimaging corroborates these findings; for instance, individuals with chronic low back pain have increased levels of translocator protein (TSPO), a marker of glial activation, in several brain regions upon TSPO-PET imaging, suggesting a potential pain-protective and anti-inflammatory role [19].”
Transcriptional and cellular signatures of cortical morphometric remodelling in chronic pain
Martins, D., Dipasquale, O., Veronese, M., Turkheimer, F., Loggia, M. L., McMahon, S., Howard, M. A., & Williams, S. C. R. (2022) · Pain · doi:10.1097/j.pain.0000000000002480 · Cited by 27
Self-citationShraim, M. A., Massé‐Alarie, H., Farrell, M. J., Cavaleri, R., Loggia, M. L., & Hodges, P. W. (2024) · European Journal of Pain · doi:10.1002/ejp.2313 · Cited by 29
“Standardized uptake values (SUV WB ) for the whole brain and for each functionally defined ROI (SUV ROI ) were calculated as (Kinahan & Fletcher, 2010; Loggia et al., 2015): were used as pseudo-reference regions for each participant (Albrecht, Normandin, et al., 2018).”
InfluentialSelf-citationNúñez‐Cortés, R., Salazar‐Méndez, J., & Nijs, J. (2025) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk10020183 · Cited by 37
“Studies have shown that glial density is increased in the brains of patients with chronic non-specific low back pain, migraine, and fibromyalgia, supporting the role of neuroinflammation in the development of chronic pain [25,26].”
McKenzie, A., Dombrower, R., Theeraphapphong, N., McKenzie, S. M., & Hijazin, M. A. (2025) · Biomedicines · doi:10.3390/biomedicines14010058 · Cited by 34
“Human neuroimaging studies support these findings, with TSPO-PET demonstrating elevated microglial activation in chronic pain patients [23].”
Jung, Y.-H., Kim, H., Jeon, S. Y., Kwon, J. M., Lee, W. J., Kim, Y. C., Jang, J. H., Choi, S., Lee, J., & Kang, D. (2018) · Pain Medicine · doi:10.1093/pm/pny111 · Cited by 29
Liu, C. H., Abrams, N., Carrick, D. M., Chander, P., Dwyer, J. T., Hamlet, M. R. J., Kindzelski, A., PrabhuDas, M., Tsai, S., Vedamony, M. M., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201902024 · Cited by 30
“positron emission tomography (PET) scans (15).”
Schaechter, J. D., Hightower, B. G., Kim, M., & Loggia, M. L. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100336 · Cited by 27
“Standardized uptake value (SUV) images were calculated (i.e., radioactivity concentration divided by injected dose per body weight) from the 60–90 min post-administration [11C]PBR28 PET data and processed as we described previously (Albrecht et al., 2018; Loggia et al., 2015).”
MethodSelf-citationSergeeva, M. G., Rech, J., Schett, G. A., & Heß, A. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0783-2 · Cited by 27
“Within the brain, peripheral cytokines act on a central network of microglia, astrocytes, and neurons, which in turn produce cytokines [26].”
Kozlowska, K., Chung, J. Z. Y., Cruickshank, B., McLean, L., Scher, S., Dale, R. C., Mohammad, S. S., Singh‐Grewal, D., Prabhuswamy, M., & Patrick, E. (2018) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-018-1212-2 · Cited by 31
Gattlen, C., Deftu, A., Tonello, R., Ling, Y., Berta, T., Ristoiu, V., & Suter, M. R. (2020) · Glia · doi:10.1002/glia.23831 · Cited by 28
A Fatal Alliance between Microglia, Inflammasomes, and Central Pain
Hoffmann, S., & Beyer, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113764 · Cited by 28
Ballantyne, J. C., & Sullivan, M. D. (2022) · Journal of Pain · doi:10.1016/j.jpain.2022.05.001 · Cited by 31
Pain-sensorimotor interactions: New perspectives and a new model
Murray, G. M., & Sessle, B. J. (2024) · Neurobiology of Pain · doi:10.1016/j.ynpai.2024.100150 · Cited by 36
“…alterations in glutamate, γ -aminobutyric acid, and N -acetyl aspartate (a neuronal marker) levels and opioid receptor binding (e.g. in frontal cortices or forebrain of patients with neuropathic pain, low back pain or fibromyalgia) (Bushnell et al., 2013; Loggia et al., 2015; Kuner and Flor, 2017).”
BackgroundKatsumi, Y., Racine, A. M., Torrado-Carvajal, Á., Loggia, M. L., Hooker, J. M., Greve, D. N., Hightower, B. G., Catana, C., Cavallari, M., Arnold, S. E., et al. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102346 · Cited by 28
“…is thought, in some cases, to contribute to transient and/or sustained cognitive decline, possibly through neuroinflammatory mechanisms (Alam et al., 2018; Cortese and Burger, 2017; Maldonado, 2013; Marcantonio, 2012; Skvarc et al., 2018; Subramaniyan and Terrando, 2019; van Harten et al., 2012).”
BackgroundSelf-citationHisaoka‐Nakashima, K., Ohata, K., Yoshimoto, N., Tokuda, S., Yoshii, N., Nakamura, Y., Wang, D., Liu, K., Wake, H., Yoshida, T., et al. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114146 · Cited by 30
Jodoin, M., Rouleau, D. M., Larson-Dupuis, C., Gosselin, N., & Beaumont, L. D. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.07.005 · Cited by 30
Human Glial Cells as Innovative Targets for the Therapy of Central Nervous System Pathologies
Magni, G., Riboldi, B., & Ceruti, S. (2024) · Cells · doi:10.3390/cells13070606 · Cited by 30
“…of glial cell activation in humans came from the discovery of the 18 kDa translocator protein, named TSPO, a five-transmembrane domain protein expressed by mitochondria in different cell types but, interestingly, specifically upregulated in astrocytes and microglia upon their activation [65].”
BackgroundGruen, M. E., Messenger, K. M., Thomson, A., Griffith, E. H., Aldrich, L. A., Vaden, S. L., & Lascelles, B. D. X. (2016) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2016.12.007 · Cited by 30
“Widespread central nervous system glial activation has also been noted in human patients with chronic lower back pain (Loggia et al., 2015).”
Feltes, P. K., de Vries, E. F. J., Juárez‐Orozco, L. E., Kurtys, E., Dierckx, R., Jeckel, C. M. M., & Doorduin, J. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17747189 · Cited by 24
“These events include cell proliferation, morphological changes, increased expression of specific cell surface markers, production of cytokines and other inflammatory mediators.(12) Depending on the type of stimulus and its duration, microglia activation can be classified as acute or chronic.”
Astrocyte and Neuronal Plasticity in the Somatosensory System
Sims, R. E., Butcher, J. B., Parri, H. R., & Glazewski, S. (2015) · Neural Plasticity · doi:10.1155/2015/732014 · Cited by 28
“Very recently, the increased activity of astrocytes and glia has also been implicated in persistent pain in humans [92].”
BackgroundChung, K. F. (2017) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2017.02.003 · Cited by 27
“Abnormal microglial responses may play a prominent part in the CNS of chronic pain patients (34).”
BackgroundTuck, N. L., Johnson, M. H., & Bean, D. J. (2018) · Journal of Pain · doi:10.1016/j.jpain.2018.07.002 · Cited by 34
Zhou, J., Chen, H., Yang, C., Zhong, J., He, W., & Xiong, Q. (2017) · Neurochemical Research · doi:10.1007/s11064-016-2170-z · Cited by 24
Inflammation and the Central Nervous System in Inflammatory Rheumatic Disease
Kaplan, C. M., Minc, A., Basu, N., & Schrepf, A. (2019) · Current Rheumatology Reports · doi:10.1007/s11926-019-0870-5 · Cited by 27
Bruun, K. D., Amris, K., Vægter, H. B., Blichfeldt‐Eckhardt, M. R., Holsgaard‐Larsen, A., Christensen, R., & Toft, P. (2021) · Trials · doi:10.1186/s13063-021-05776-7 · Cited by 24
“The proposed mechanisms of action of LDN on pain are 1) opioid antagonism, which leads to a feedbackmediated increased expression of opioid receptors in the central nervous system (CNS) [7, 8] with a possible improvement of the endorphin system and 2) an antiinflammatory effect, mediated through inhibition of Toll-lik…”
BackgroundSchipholt, I. J. L., Coppieters, M. W., Meijer, O. G., Tompra, N., de Vries, R. B. M., & Scholten-Peeters, G. G. M. (2021) · PAIN Reports · doi:10.1097/pr9.0000000000000927 · Cited by 29
Kang, D., Hesam‐Shariati, N., McAuley, J. H., Alam, M., Trost, Z., Rae, C. D., & Gustin, S. M. (2021) · European Journal of Pain · doi:10.1002/ejp.1838 · Cited by 29
“(Loggia et al., 2015) has shown glial activation in vivo in the brains of people with chronic back pain, which is commonly known as nonneuropathic pain.”
BackgroundForsberg, A., Lampa, J., Estelius, J., Červenka, S., Farde, L., Halldin, C., Lekander, M., Höglund, C. O., & Kosek, E. (2019) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.577000 · Cited by 25
“Furthermore, in order to reduce variability, ratio-based approaches such as standardized uptake ratio (SUVr) and distribution volume ratio (DVR) have been employed in clinical studies using [11C]PBR28 (Albrecht et al., 2018c; Kreisl et al., 2013b; Loggia et al., 2015; Lyoo et al., 2015).”
MethodBarowsky, S., Jung, J.-Y., Nesbit, N., Silberstein, M. D., Fava, M., Loggia, M. L., Smoller, J. W., & Lee, P. H. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.687687 · Cited by 24
Self-citationSubliminal (latent) processing of pain and its evolution to conscious awareness
Borsook, D., Youssef, A. M., Barakat, N., Sieberg, C. B., & Elman, I. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.015 · Cited by 21
The Role of the Thalamus in Nociception: Important but Forgotten
Galdino, G., Veras, F. P., & dos Anjos‐Garcia, T. (2024) · Brain Sciences · doi:10.3390/brainsci14080741 · Cited by 26
“…glial activity in the thalamus of patients with chronic low back pain was veri fi ed in studies using positron emission tomography, which detects [11C]-PBR28, a radioligand that binds to the 18 kDa translocator protein (TSPO), a mitochondrial molecule used as glial activation marker [86,87]. pain.”
MethodCavestro, C. (2025) · Brain Sciences · doi:10.3390/brainsci15050474 · Cited by 28
The Pelvic Girdle Pain deadlock: 2. Topics that, so far, have remained out of focus
Meijer, O. G., Barbe, M. F., Prins, M. R., Schipholt, I. J. L., Hu, H., & Daffertshofer, A. (2020) · Musculoskeletal Science and Practice · doi:10.1016/j.msksp.2020.102166 · Cited by 24
Bjurström, M. F., Bodelsson, M., Montgomery, A. K., Harsten, A., Waldén, M., Janelidze, S., Hall, S., Hansson, O., Irwin, M. R., & Mattsson, N. (2020) · Pain · doi:10.1097/j.pain.0000000000001903 · Cited by 25
Astrocytic Calcium Dynamics Along the Pain Pathway
Cho, J., & Huh, Y. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.594216 · Cited by 24
“%) by excitatory amino-acid transporter (EAAT)-1 and 2, which are predominantly expressed in astrocytes (Mahmoud et al., 2019).”
BackgroundUpdated review on the link between cortical spreading depression and headache disorders
Vurallı, D., Karataş, H., Yemişçi, M., & Bolay, H. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1947797 · Cited by 25
Microglial inflammation modulates opioid analgesic tolerance
Pahan, P., & Xie, J. Y. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25199 · Cited by 22
“These changes are similar to the microglia activation induced by inflammation or neuropathic pain (Gu et al., 2022; Loggia et al., 2015; Roberts et al., 2009).”
BackgroundMazzitelli, M., Ponomareva, O., Presto, P., John, J., & Neugebauer, V. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1368634 · Cited by 26
“…as in various brain regions, including thalamus, somatosensory cortex, cingulate cortex and ventromedial prefrontal cortex, in patients suffering from chronic pain (Loggia et al., 2015; Albrecht et al., 2019; Albrecht et al., 2021), supporting the translational relevance of this line of research.”
Unconventional Role of Caspase-6 in Spinal Microglia Activation and Chronic Pain
Berta, T., Lee, J. E., & Park, C. (2017) · Mediators of Inflammation · doi:10.1155/2017/9383184 · Cited by 21
“Although human studies have established glial activation in chronic pain states using functional magnetic resonance imaging [70] and in postmortem spinal cords [71], clinical trial with inhibitors targeting microglia, such as minocycline (a tetracycline antibiotic) and propentofylline (a CNS glial modulator), has show…”
BackgroundBai, X., Batallé, G., & Pol, O. (2021) · Antioxidants · doi:10.3390/antiox10071074 · Cited by 21
“In accordance, microglial activation has been shown in different brain regions of depressive patients suffering chronic pain [16] and in the hippocampus of animals with anxiety- and depressive-like behaviors associated with neuropathic pain [15,24].”
BackgroundImmunity and pain in the eye: focus on the ocular surface
Vitar, R. M. L., Bonelli, F., Rama, P., & Ferrari, G. (2021) · Clinical & Experimental Immunology · doi:10.1093/cei/uxab032 · Cited by 20
Malange, K. F., Pelaez, J. M. N., Dias, E. V., Lemes, J. B. P., Choi, S., dos Santos, G. G., Yaksh, T. L., & Corr, M. (2022) · Frontiers in Pain Research · doi:10.3389/fpain.2022.1018800 · Cited by 28
“Imaging studies using the radioligand 11C-PBR28, showed an increase in brain levels of the translocator protein (TSPO), a marker of glial activation, in people with low back pain and fibromyalgia (201, 202).”
MethodTSPO-PET Imaging to Assess Cerebral Microglial Activation in Multiple Sclerosis
Weiner, H. L., Bakshi, R., & Singhal, T. (2017) · Seminars in Neurology · doi:10.1055/s-0037-1608715 · Cited by 18
Supraspinal neuroimmune crosstalk in chronic pain states
Austin, P. J., & Fiore, N. T. (2019) · Current Opinion in Physiology · doi:10.1016/j.cophys.2019.03.008 · Cited by 26
Sandström, A., Torrado-Carvajal, Á., Morrissey, E. J., Kim, M., Alshelh, Z., Zhu, Y., Li, M., Chang, C. Y., Jarraya, M., Akeju, O., et al. (2023) · Pain · doi:10.1097/j.pain.0000000000003114 · Cited by 18
Self-citationRosenström, A. H. C., Ahmed, A. S., Kultima, K., Freyhult, E., Berg, S., Farinotti, A. B., Palada, V., Svensson, C. I., & Kosek, E. (2024) · Pain · doi:10.1097/j.pain.0000000000003175 · Cited by 22
“2,45 Elevated cytokine levels in the cerebrospinal fluid (CSF), often referred to as neuroinflammation, have been reported in patients suffering from neuropathic, 7,11,40,52 nociceptive, 19,37,53 as well as nociplastic pain.”
Coronel, M. F., Granel, M. L. S., Raggio, M. C., Adler, N. S., Nicola, A. F. D., Labombarda, F., & González, S. L. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.04.067 · Cited by 18
“…levels of TSPO negatively correlate with clinical pain and circulating levels of the pro-inflammatory cytokine interleukin-6 in patients with chronic back pain, suggesting that TSPO exerts pain-protective/anti-inflammatory effects in humans, as predicted by animal studies (Loggia et al. 2015).”
New Therapeutic Targets for Osteoarthritis Pain
Walsh, D. A., & Stocks, J. (2017) · SLAS DISCOVERY · doi:10.1177/2472555217716912 · Cited by 26
Trigeminal nerve microstructure is linked with neuroinflammation and brainstem activity in migraine
Tohyama, S., Datko, M., Brusaferri, L., Kinder, L. D., Schnieders, J. H., Hyman, M., Goldstein, A. M., Gilbert, M. D., Housman, H., Le, V., et al. (2025) · Brain · doi:10.1093/brain/awaf029 · Cited by 21
Self-citationDescending Pain Modulation in Fibromyalgia: A Short Review of Mechanisms and Biomarkers
Carneiro, B. D., Torres, S., Costa‐Pereira, J. T., Pozza, D. H., & Tavares, I. (2025) · Diagnostics · doi:10.3390/diagnostics15212702 · Cited by 26
“In addition, PET imaging using TSPO ligands, such as PBR28 and DPA-714, has revealed increased microglial activation in cortical regions suggesting neuroinflammation as a central mechanism [86,105].”
Reiss, D. J., Maurin, H., Audouard, E., Martínez‐Navarro, M., Xue, Y., Hérault, Y., Maldonado, R. J., Cabañero, D., & Gavériaux‐Ruff, C. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.745178 · Cited by 22
“The mechanisms involved in this promotion of cold allodynia remain to be identified (MacDonald et al., 2020).”
BackgroundThe role of adenosine and P2Y receptors expressed by multiple cell types in pain transmission
Magni, G., & Ceruti, S. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.02.011 · Cited by 19
Cabarga, L., Batallé, G., & Pol, O. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120913154 · Cited by 17
“Microglial and astroglial activation have been demonstrated in several brain areas like the amygdala, hippocampus and prefrontal cortex (PFC) of patients and animals with chronic pain, contributing to the progress of the emotional disorders accompanying chronic neuropathic pain (Eto et al., 2018; Ferreira-Chamorro et…”
BackgroundInfluentialRoyds, J., Conroy, M. J., Dunne, M. R., Cassidy, H., Matallanas, D., Lysaght, J., & McCrory, C. R. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577249 · Cited by 20
“Radiolabelled TSPO is upregulated in the CNS in many chronic pain patients compared to controls with chronic back pain (Albrecht et al., 2018b; Loggia et al., 2015), Complex Regional Pain Syndrome (CRPS)(Jeon et al., 2017), fibromyalgia (Albrecht et al., 2018b) and lumbar radicular pain (Albrecht…”
BackgroundYang, M., Kong, E., Song, H., Zhang, X., Feng, X., Tong, H., Wei, H., Chen, Q., & Yuan, H. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.04.016 · Cited by 17
“Persistent activation of glial cells leads to sustained neuroinflammation, which is a key driver of pain sensitization (Loggia et al., 2015; Jiang et al., 2016).”
Bjurström, M. F., Bodelsson, M., Irwin, M. R., Orbjörn, C., Hansson, O., & Mattsson, N. (2021) · Pain Practice · doi:10.1111/papr.13051 · Cited by 19
“Moreover, in patients with chronic low back pain, increased thalamic levels of the translocator protein, which is upregulated in activated microglia and astrocytes, is associated with lower pain intensity.(51) Although studies examining associations between QST measures of pain and CSF proinflammatory mediators are ra…”
BackgroundFerrante, M., Inglese, M., Brusaferri, L., Whitehead, A. C., Maccioni, L., Turkheimer, F., Nettis, M. A., Mondelli, V., Howes, O. D., Loggia, M. L., et al. (2024) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2024.108375 · Cited by 19
Self-citationTejada, M. A., Montilla‐García, Á., González‐Cano, R., Bravo‐Caparrós, I., Ruiz‐Cantero, M. C., Nieto, F. R., & Cobos, E. J. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.008 · Cited by 18
Woodworth, D. C., Dagher, A. M., Curatolo, A. S., Sachdev, M., Ashe-McNalley, C., Naliboff, B. D., Labus, J. S., Landis, J. R., Kutch, J. J., Mayer, E. A., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0206807 · Cited by 16
“Another potential mechanism to explain the observations in the current study may be degenerative changes in the brain resulting from neuroinflammation, particularly due to glial activation, which was recently targeted for imaging in chronic lower back pain patients using positron emission tomography (PET) [79].”
BackgroundInfluentialAn investigation into the modulation of T cell phenotypes by amitriptyline and nortriptyline
Royds, J., Conroy, M. J., Dunne, M. R., McCrory, C. R., & Lysaght, J. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.12.106 · Cited by 20
Significant new quantitative EGG patterns in fibromyalgia
López, J. N., del Moral, R., & Marijuán, P. C. (2015) · The European Journal of Psychiatry · doi:10.4321/s0213-61632015000400005 · Cited by 19
Neuron–microglia interactions modulating neuropathic pain
Kohno, K., & Tsuda, M. (2025) · International Immunology · doi:10.1093/intimm/dxaf022 · Cited by 19
Perera, C. J., Lees, J. G., Duffy, S. S., Makker, P. G. S., Fivelman, B., Apostolopoulos, V., & Moalem‐Taylor, G. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.07.004 · Cited by 15
“The thalamic levels of translocator protein, presumably exerting painprotective effects, were negatively correlated with clinical pain and levels of circulating proinflammatory cytokines (Loggia et al., 2015).”
BackgroundChen, S., Zang, Y., Zheng, W., Wei, X., & Liu, X. (2016) · The Chinese Journal of Physiology · doi:10.4077/cjp.2016.bad332 · Cited by 16
“Previous studies have reported that TSPO level in the brain was increased in patients with chronic low back pain (23) and that diazepam can readily be distributed into the different regions of brain tissues (16), it is possible that diazepam also exerts effects via binding to recepors in the brain.”
BackgroundChamaa, F., Chebaro, M. M., Safieh‐Garabedian, B., Saadeh, R., Jabbur, S. J., & Saadé, N. E. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.05.005 · Cited by 15
“…of glia and to infiltrated resident immune cells in the nervous system (Aguzzi et al., 2013; Alexander et al., 2007; Calvo et al., 2012; Grace et al., 2014; Loggia et al., 2015; McMahon et al., 2005; Milligan and Watkins, 2009; Obata et al., 2010; Raghavendra et al., 2003; Watkins and Maier, 2002).”
InfluentialSari, H., Galbusera, R., Bonnier, G., Lin, Y., Alshelh, Z., Torrado-Carvajal, Á., Mukerji, S. S., Ratai, E., Gandhi, R. T., Chu, J. T., et al. (2022) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001144 · Cited by 15
Self-citationChronic Primary Pain of the Spine: an Integrative Perspective Part 1
Williamson, T. J., Bolles, C. L., Hedges, N. A., & Kettner, N. W. (2021) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-021-00772-z · Cited by 15
Functional brain mapping in patients with chronic back pain shows age-related differences
Baran, T. M., Lin, F. V., & Geha, P. (2021) · Pain · doi:10.1097/j.pain.0000000000002534 · Cited by 14
Morrissey, E. J., Alshelh, Z., Knight, P. C., Saha, A., Kim, M., Torrado-Carvajal, Á., Zhang, Y., Edwards, R. R., Pike, C., Locascio, J. J., et al. (2023) · Contemporary Clinical Trials · doi:10.1016/j.cct.2023.107087 · Cited by 16
Self-citationHmgb1 Silencing in the Amygdala Inhibits Pain-Related Behaviors in a Rat Model of Neuropathic Pain
Presto, P., Ji, G., Ponomareva, O., Ponomarev, I., & Neugebauer, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511944 · Cited by 15
“However, neuroimmune signaling in the brain is an understudied area of pain research despite evidence from clinical studies [8,9].”
BackgroundThe role and treatment potential of the complement pathway in chronic pain
Vygonskaya, M., Wu, Y., Price, T. J., Chen, Z., Smith, M. T., Klyne, D. M., & Han, F. Y. (2024) · Journal of Pain · doi:10.1016/j.jpain.2024.104689 · Cited by 15
Do cytokines play a role in the transition from acute to chronic musculoskeletal pain?
Ebersberger, A., & Schaible, H. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107585 · Cited by 17
Role of NLRP3 Inflammasome in Chronic Pain and Alzheimer's Disease—A Review
Moradi, F., & Mokhtari, T. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70071 · Cited by 18
“PET ‐ MRI imaging results have revealed increased astrocyte and microglia activation in the thalamus of patients with chronic lower back pain [151].”
Kringel, D., Kaunisto, M. A., Kalso, E. A., & Lötsch, J. (2019) · Pain · doi:10.1097/j.pain.0000000000001616 · Cited by 14
Lind, A., Just, D., Mikus, M. S., Fredolini, C., Ioannou, M., Gerdle, B. U. C., Ghafouri, B., Bäckryd, E., Tanum, L., Gordh, T., et al. (2019) · Journal of Pain Research · doi:10.2147/jpr.s215348 · Cited by 20
“Although interference cannot be ruled out, there are indications from other studies that drugs do not necessarily interfere with the protein profile in CSF(50) or on glial activation in patients.(139)”
ResultModulation of Neuropathic Pain by Glial Regulation in the Insular Cortex of Rats
Choi, S., Kim, K., Kwon, M., Bai, S. J., Cha, M., & Lee, B. H. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.815945 · Cited by 15
Low back pain: Moving toward mechanism-based management
Mousavi, S. J., van Dieën, J. H., & Anderson, D. (2018) · Clinical Biomechanics · doi:10.1016/j.clinbiomech.2018.12.010 · Cited by 14
Touj, S., Houle, S., Ramla, D., Jeffrey‐Gauthier, R., Hotta, H., Bronchti, G., Martinoli, M., & Piché, M. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.03.047 · Cited by 17
Guo, M., Jiang, Z., YongHao, C., Wang, F., & Wang, Z. (2021) · The Korean journal of pain · doi:10.3344/kjp.2021.34.2.176 · Cited by 13
“Due to the membrane-bound property of IL-6 complexes, the majority of cells lack membrane-bound IL-6R, and consequently do not respond to IL-6 [29,30].”
BackgroundHow Accurate Appraisal of Behavioral Costs and Benefits Guides Adaptive Pain Coping
Gandhi, W., Morrison, I., & Schweinhardt, P. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00103 · Cited by 18
“Activation of glia cells, an important constituent of neuroinflammation, has indeed been observed in the brains of patients with chronic low back pain (117).”
BackgroundPalada, V., Ahmed, A. S., Hugo, A. K., Radojčić, M. R., Svensson, C. I., & Kosek, E. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa565 · Cited by 13
Cheng, C.-H., Alshelh, Z., Guan, Y., Sullivan, K. A., Loggia, M. L., & Koo, B. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100364 · Cited by 14
“However, the current PET analysis method, using SUVR images from data collected over the 60-90 min post-injection [11C]PBR28 PET interval, was determined from studies on chronic pain and amyotrophic lateral sclerosis, therefore, would require further validation in larger GW veteran cohorts (Loggia et al., 2015; Zurche…”
MethodSelf-citationChronic non-inflammatory muscle pain: central and peripheral mediators
Lesnak, J. B., & Sluka, K. A. (2019) · Current Opinion in Physiology · doi:10.1016/j.cophys.2019.06.006 · Cited by 19
“In individuals with chronic pain, FM and low back pain, positron emission tomography (PET) using a glial activation marker, translocator protein (TPSO), show enhanced activity in the cingulate cortices; this activity correlates with fatigue(82, 83).”
BackgroundPeng, K., Karunakaran, K. D., Labadie, R. F., Veliu, M., Cheung, C., Lee, A. M., Yu, P. B., & Upadhyay, J. (2021) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-01709-4 · Cited by 13
Metadata
- Authors
- Loggia, M. L., Chonde, D. B., Akeju, O., Arabasz, G., Catana, C., Edwards, R. R., Hill, E., Hsu, S., Izquierdo-Garcia, D., Ji, R.-R., Riley, M., Wasan, A. D., Zürcher, N. R., Albrecht, D. S., Vangel, M. G., Rosen, B. R., Napadow, V., & Hooker, J. M.
- Affiliations
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Massachusetts General Hospital (US)
- Tufts University (US)
- Corresponding author
- Loggia, Marco L.
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-01-08
- Volume
- 138
- Issue
- 3
- Pages
- 604-615
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC4339770
- OpenAlex
- W2135235221
- Cited by
- 503
- References
- 98
- Citations by year
- 2026: 43 · 2025: 55 · 2024: 36 · 2023: 27 · 2022: 30 · 2021: 51 · 2020: 46 · 2019: 49 · 2018: 53 · 2017: 47 · 2016: 42 · 2015: 24
- FWCI
- 40.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Brain (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Massachusetts General Hospital (1UL1TR001102)
- Harvard University
- Harvard Catalyst (1 UL1 TR 001102, 8 UL1 TR000170-05, 1UL1TR001102-01, 8UL1TR000170)
- National Institutes of Health (UL1TR000170, UL1TR001102, 1UL1TR0011-02)
- National Institute of Neurological Disorders and Stroke (R21NS087472)
- National Institute of Biomedical Imaging and Bioengineering (R01EB014894, T32EB013180)
- National Institute of Dental and Craniofacial Research (R01DE022743)
- National Center for Research Resources (S10RR022976, S10RR026666, UL1RR025758, S10RR023385)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
- Keywords
- chronic low back pain, glial activation, translocator protein (TSPO), microglia, astrocytes, chronic pain, thalamus, interleukin-6, anti-inflammatory activity, somatosensory representation
- MeSH terms
- Adult, Aged, Brain, Female, Genotype, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Neuroglia, Pyrimidines, Statistics as Topic, Interleukin-6, Case-Control Studies, Receptors, GABA, Polymorphism, Single Nucleotide, Positron-Emission Tomography, Chronic Pain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.